<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220222054101N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-06-18</date_registration>
      <primary_sponsor>Qazvin University of Medical Sciences</primary_sponsor>
      <public_title>Comparative study of the Effect of Desensitization with Eye movements and Reprocessing on the fear of Covid 19 in a virtual and real way on nurses</public_title>
      <acronym></acronym>
      <scientific_title>Comparative study of the Effect of Desensitization with Eye movements and Reprocessing on the fear of Covid 19 in a virtual and real way on nurses</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-06-18</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>159</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63746</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Other, Purpose: Supportive, Randomization description: Eligible applicants will be able to register with the willingness to participate in the study. Then, with the method of 6 random blocking, random assignment of participants in three groups with a ratio of 1: 1: 1 will be done. Random allocation sequence generation software will be used to determine the allocation sequence by 6-block method. To hide the allocation sequence, the papers identifying the group of individuals are placed inside the envelopes in the opaque package, respectively, and encoded in the same way. In this case, for the person who receives the intervention code 1, a questionnaire with the same code is completed.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Fear of covid 19.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: real:  Content of sessions in at least 2 sessions of 90 to 45 minutes twice a week and by performing  Eye movement desensitization and reprocessing (EMDR)in hospitals affiliated to Qazvin University of Medical Sciences in a suitable and quiet atmosphere to focus on the intervention of nurses, after initial explanations about EMDR and How to do it and about its advantages will be done in the first session. During the intervention, the control group will work as usual. A psychiatric nursing graduate student who has completed and mastered the EMDR course will be the presenter and performer of the technique. Intervention sessions continue as long as the Mental Disorder Scale Subjective Units of Disturbance (SUD) is a fixed number in two sessions. Intervention 2: Intervention group: virtual:  After explaining the therapist about Eye Movement Desensitization and Reprocessing  (EMDR)  and how to do it and how to use the video, as well as about the benefits and functionality of the EMDR video content prepared by the master student of psychiatry, the player and the therapist on a handheld computer Performs the necessary checks in the presence of the client and makes sure that the client does it correctly. After using the video, they will be asked to complete the Covid Fear Questionnaire. Intervention sessions will continue as long as the Subjective Units of Disturbance (SUD) is a fixed number in two sessions. Intervention 3: Control group: just they fill the scales before T after T and 3 month later.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Comparative study of the Effect of Desensitization with Eye movements and Reprocessing on the fear of Covid 19 in a virtual and real way on nurses working in Qazvin hospitals: Randomized Clinical Trial

When:
6 month after Publish of results

To whom:
Nursing students

Conditions:
Direct permission

Where to obtain:
smahdimousavi7@gmail.com send an email

How to obtain:
Direct permission

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyyed Mahdi Mousavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 36, 8th Golafshan Ave, Sayyad street , Abhar town</address>
        <city>Abhar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4566155179</zip>
        <telephone>+98 24 3525 0056</telephone>
        <email>SMAHDIMOUSAVI7@GMAIL.COM</email>
        <affiliation>Qazvin University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammadreza Sheikhi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University Campus, Office Complex, Qazvin University of Medical Sciences, Shahid Bahonar Blvd, North Navab St, Qazvin town</address>
        <city>Qazvin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15315-34199</zip>
        <telephone>+98 912 282 1450</telephone>
        <email>mmsheikhi1@yahoo.com</email>
        <affiliation>Qazvin University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Have a bachelor's degree in nursing or higher
Activity in the covid19 ward for at least 6 months
Complete satisfaction to enter into partnership
Do not take other educational interventions at the same time as the plan
Having an account on one of the social networks with video communication</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Intolerance and resilience of the person during desensitization with eye movements and reprocessing,
Having a DSM-5 based mental illness leads to hospitalization
visit a psychiatrist and take medication
vision impairment by self report
Taking psychotropic drugs
Having a history of PTSD, self-purifying</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z71.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Person with feared health complaint in whom no diagnosis is made</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: real:  Content of sessions in at least 2 sessions of 90 to 45 minutes twice a week and by performing  Eye movement desensitization and reprocessing (EMDR)in hospitals affiliated to Qazvin University of Medical Sciences in a suitable and quiet atmosphere to focus on the intervention of nurses, after initial explanations about EMDR and How to do it and about its advantages will be done in the first session. During the intervention, the control group will work as usual. A psychiatric nursing graduate student who has completed and mastered the EMDR course will be the presenter and performer of the technique. Intervention sessions continue as long as the Mental Disorder Scale Subjective Units of Disturbance (SUD) is a fixed number in two sessions.</i_keyword>
      <i_keyword>Intervention group: virtual:  After explaining the therapist about Eye Movement Desensitization and Reprocessing  (EMDR)  and how to do it and how to use the video, as well as about the benefits and functionality of the EMDR video content prepared by the master student of psychiatry, the player and the therapist on a handheld computer Performs the necessary checks in the presence of the client and makes sure that the client does it correctly. After using the video, they will be asked to complete the Covid Fear Questionnaire. Intervention sessions will continue as long as the Subjective Units of Disturbance (SUD) is a fixed number in two sessions.</i_keyword>
      <i_keyword>Control group: just they fill the scales before T after T and 3 month later</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Fear of covid 19. Timepoint: Before intervention, immediately after intervention, 3 months after intervention. Method of measurement: The Fear of COVID-19 Scale FCV-19S.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Anxiety and depression after  confronting covid 19. Timepoint: Before intervention, immediately after intervention, 3 months after intervention. Method of measurement: Hospital anxiety depression scale  HADS.</sec_outcome>
      <sec_outcome>Quality of working life after  confronting covid 19. Timepoint: Before intervention, immediately after intervention, 3 months after intervention. Method of measurement: Quality of working life (QWL).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for research of Qazvin University of medical sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-05-09</approval_date>
        <contact_name>Ethics Committees of Qazvin University of Medical Sciences</contact_name>
        <contact_address>Pardis of university,staff of Qazvin university of medical science,Complex of offices,Shahid Bahonar blvd, Navab shomal st,Qazvin town Qazvin Qazvin Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
